[The significance of gynecomastia in general practice]
- PMID: 2659478
[The significance of gynecomastia in general practice]
Abstract
Gynecomastia in the male is usually due to a change of the estradiol/testosterone ratio in favor of the estrogens. There is usually no need for therapy of the gynecomastia which frequently occurs during puberty and old age. However, it is important not to overlook hormone-secreting tumors, often testicular malignancies, as the underlying cause of gynecomastia. A careful history and clinical investigations including thorough palpation of the testes (sonography) are complemented by a laboratory workup including blood chemistry (liver function) and hormone determinations (estradiol, beta-HCG, FSH, LH, prolactin, testosterone, thyroid hormones). Treatment of gynecomastia includes elimination of the cause of the condition. In cases with fibrous and voluminous gynecomastia breast tissue must be removed surgically. Antiestrogenic treatment with tamoxifen is indicated only in patients with recently developed, tender gynecomastia.
Similar articles
-
EAA clinical practice guidelines-gynecomastia evaluation and management.Andrology. 2019 Nov;7(6):778-793. doi: 10.1111/andr.12636. Epub 2019 May 16. Andrology. 2019. PMID: 31099174
-
[Evaluation and management of gynecomastia].Rev Med Suisse. 2009 Apr 8;5(198):783-7. Rev Med Suisse. 2009. PMID: 19418981 French.
-
[Testosterone and estradiol levels in male gynecomastia. Clinical and endocrine findings during treatment with tamoxifen].Dtsch Med Wochenschr. 1984 Nov 2;109(44):1678-82. doi: 10.1055/s-2008-1069434. Dtsch Med Wochenschr. 1984. PMID: 6489180 German.
-
Gynecomastia.Endocrinol Metab Clin North Am. 2007 Jun;36(2):497-519. doi: 10.1016/j.ecl.2007.03.013. Endocrinol Metab Clin North Am. 2007. PMID: 17543732 Review.
-
Evaluation and treatment of gynecomastia.Am Fam Physician. 1997 Apr;55(5):1835-44, 1849-50. Am Fam Physician. 1997. PMID: 9105209 Review.